neurotherapeutics

D. Neurotherapeutics in Multiple Sclerosis: Novel Agents and Emerging Treatment Strategies.

The American Society for Experimental NeuroTherapeutics, Inc, "Observational Versus Experimental Studies: What's the Evidence for a Hierarchy?"

Dr. Darin D. Dougherty, director of the division of neurotherapeutics at Massachusetts General Hospital and an associate professor of psychiatry at Harvard, put it more bluntly.

Jeffrey Alan Cohen (born October 14, 1954) is an American Neurologist specializing in Multiple Sclerosis and Director of Experimental Neurotherapeutics at the Cleveland Clinic Mellen Center for Multiple Sclerosis.

He was the Director of the Mary S. Easton Center for Alzheimer's Disease Research at UCLA and Director of the Deane F. Johnson Center for Neurotherapeutics at UCLA.